Gulf Biomedical Receives Global Interest from Distributors and Retail Stores in Herbal Market; Renewal Orders of 'HairMagic(TM)' Remain Strong.
The recent attention provides GBIC with a positive outlook heading into 2006 with multiple lines of products set to hit the market. These products are anticipated to generate significant residual revenues. Management anticipates as GBIC enters the global market, residual orders will spark brand recognition with strong cash flow.
Presently, Gulf Biomedical has received positive feedback from its customers regarding the all natural hair restoration pill "HairMagic(TM)". Renewal orders for the hair restoration pills are continuing to be processed through out the week with first time orders increasing each month. HairMagics hair restoration pill is only one of a projected 24 "herbals" in the "Magic" line.
Don West President of Gulf Biomedical stated, "All the attention is unexpected and a little overwhelming, but it tells us that our firm is on the right track. Our main concern right now is to have at least six products to hit the market by the first quarter of 2006. At this time, we are on track to do that." Mr. West continued to state in the coming weeks and months we will be releasing to the public "LoveMagic" which is an all natural substitute for erectile dysfunction drugs. Other all-natural products which are in the pipeline during this time are supplements to address depression, aging, memory loss and excess weight gain. These formulas have been demonstrated to be effective, and comprise no known side effects."
For additional information on Gulf Biomedical, please contact Investor Relations at (973) 351-3868 or contact customer service at (973) 375-5002.
Disclaimer: This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of l995 relating to aspects of the Company's operations and strategies. Important factors could occur to cause actual results to differ materially from those described herein. There is a risk that the Company may incur losses. Readers are urged to consider these cautionary statements carefully. Forward-looking statements speak only as of the date of this news release, and the Company disclaims any obligations to update such statements.